Neo Ivy Capital Management’s Merck MRK Stock Holding History

Neo Ivy Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-9,718	Closed	-$769K	–	488
2025 Q2	$769K	Sell	9,718 -35,530	-79%	-$2.82M	0.25%	145
2025 Q1	$4.06M	Buy	45,248 +18,083	+67%	+$1.69M	1.29%	7
2024 Q4	$2.7M	Sell	27,165 -7,165	-21%	-$739K	0.54%	77
2024 Q3	$3.9M	Buy	+34,330	New	+$4.08M	1.26%	9
2022 Q4	–	Sell	-1,849	Closed	-$159K	–	480
2022 Q3	$159K	Sell	1,849 -773	-29%	-$69K	0.42%	90
2022 Q2	$239K	Sell	2,622 -9,952	-79%	-$882K	0.64%	37
2022 Q1	$1.03M	Buy	12,574 +6,978	+125%	+$550K	0.93%	4
2021 Q4	$429K	Buy	+5,596	New	+$446K	0.62%	36
2020 Q2	–	Sell	-4,422	Closed	-$325K	–	545
2020 Q1	$325K	Buy	+4,422	New	+$348K	0.53%	42

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Neo Ivy Capital Management's MRK Position: Q3 2025 in Review

Neo Ivy Capital Management sold out of Merck (MRK) in Q3 2025, closing a stake of 9,718 shares — an estimated $769K sold.

Neo Ivy Capital Management first reported a position in MRK in Q1 2020 and held it in 9 quarters. The position peaked at $4.06M in Q1 2025. 3,310 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

Neo Ivy Capital Management reported no remaining Merck position as of Q3 2025 after selling out during the quarter.
Neo Ivy Capital Management sold 9,718 Merck shares in Q3 2025, an estimated $769K.
Neo Ivy Capital Management first reported a position in Merck in Q1 2020 and held it in 9 quarters.
Neo Ivy Capital Management's Merck position peaked at $4.06M in Q1 2025.
3,310 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on Neo Ivy Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.